Latest Blog Posts
Search
Sort Results
Filter by Programming
Filter by Specific Population
Filter by Topic
- Organ and body health (47)
- Infections and cancers (20)
- Disease progression (14)
- Reproductive and maternal health (14)
- Emotional health (12)
- Prevention interventions (7)
- Social determinants of health (6)
- Testing and diagnosis (6)
- Harm reduction and substance use (4)
- Healthy living (2)
- Government and community strategies (1)
- Transmission and risk (1)
Filter by Infection
Filter by Resource Category
- Research summary (remove)
Search results
Current filters: Treatment, Research summary, English
266 search results
- Revisiting TDF + FTC as a potential preventive for COVID-19
-
From TreatmentUpdate 238
2020, CATIE
Research summary - Webpage - Triple therapy with interferon-beta + Kaletra + ribavirin
-
From TreatmentUpdate 237
2020, CATIE
Research summary - Webpage - Kaletra—from HIV to SARS to COVID-19
-
From TreatmentUpdate 237
2020, CATIE
Research summary - Webpage - Kaletra disappointing in people severely ill with COVID-19
-
2020, CATIE
Research summary - Webpage - Canadian trends in hepatitis C virus treatment for people co-infected with HCV and HIV
-
2020, CATIE
Research summary - Webpage - Might cost issues affect the success of HIV care programs in the future?
-
2020, CATIE
Research summary - Webpage - Improved health when treatment for both hepatitis C and opioid use disorder are offered
-
2020, CATIE
Research summary - Webpage - Managing medicines may become more difficult as some HIV-positive people age
-
2020, CATIE
Research summary - Webpage - Hepatitis C treatment in harm reduction programs for people who use drugs
-
From Prevention in Focus - Spring 2020
2020, CATIE
Research summary - Webpage - Dolutegravir and TAF or TDF—safety issues and weight gain
-
From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage
